Redx Pharma Plc (REDX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2018 | 09-2017 | 09-2016 | 09-2015 | 09-2014 | |
| Sales | 129 | 30,474 | N/A | N/A | 0 |
| Operating Expenses | 9,328 | 17,091 | 14,392 | 9,431 | 2,835 |
| Operating Income | -9,199 | 13,383 | -14,392 | -9,431 | -2,835 |
| Interest Expense | 1 | 368 | 346 | 348 | 249 |
| Other Income | -946 | -11,369 | -669 | 954 | -1,179 |
| Pre-tax Income | -10,146 | 1,646 | -15,407 | -8,825 | -4,263 |
| Income Tax | -1,301 | 118 | 114 | -650 | -910 |
| Net Income Continuous | -8,845 | 1,528 | -15,521 | -8,175 | -3,353 |
| Net Income | $-8,845 | $1,528 | $-15,521 | $-8,175 | $-3,353 |
| EPS Basic Total Ops | -0.07 | 0.01 | -0.20 | -0.14 | -0.05 |
| EPS Basic Continuous Ops | -0.07 | 0.01 | -0.20 | -0.14 | -0.05 |
| EPS Diluted Total Ops | -0.07 | 0.01 | -0.20 | -0.14 | -0.05 |
| EPS Diluted Continuous Ops | -0.07 | 0.01 | -0.20 | -0.14 | -0.05 |
| EBITDA(a) | $-9,981 | $2,341 | $-14,799 | $-8,338 | $-3,762 |